Deferred Tax Assets, Valuation Allowance of HOOKIPA Pharma Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
HOOKIPA Pharma Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • HOOKIPA Pharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $93,382,000, a 4.6% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HOOKIPA Pharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $93,382,000 +$4,073,000 +4.6% 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q4 2023 $89,309,000 +$23,535,000 +36% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $65,774,000 +$12,046,000 +22% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q4 2021 $53,728,000 +$7,664,000 +17% 31 Dec 2021 10-K 28 Feb 2025 2024 FY
Q4 2020 $46,064,000 +$13,481,000 +41% 31 Dec 2020 10-K 22 Mar 2024 2023 FY
Q4 2019 $32,583,000 +$13,427,000 +70% 31 Dec 2019 10-K 15 Mar 2023 2022 FY
Q4 2018 $19,156,000 +$5,367,000 +39% 31 Dec 2018 10-K 24 Mar 2022 2021 FY
Q4 2017 $13,789,000 +$5,411,000 +65% 31 Dec 2017 10-K 18 Mar 2021 2020 FY
Q4 2016 $8,378,000 31 Dec 2016 10-K 19 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.